Head and neck squamous cell carcinoma vaccine: Current landscape and perspectives
The treatment of unresectable or metastatic Head and Neck Squamous Cell Carcinoma
(HNSCC) has traditionally relied on chemotherapy or radiotherapy, yielding suboptimal …
(HNSCC) has traditionally relied on chemotherapy or radiotherapy, yielding suboptimal …
Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
A Meci, N Goyal, G Slonimsky - Cancers, 2024 - mdpi.com
Simple Summary The programmed death-1 receptor monoclonal antibody treatments
pembrolizumab and nivolumab have been successful in the treatment of recurrent or …
pembrolizumab and nivolumab have been successful in the treatment of recurrent or …
Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy
AJ Rosenberg, CA Perez, W Guo… - American Society of …, 2024 - ascopubs.org
The treatment for recurrent/metastatic (R/M) head and neck squamous cell carcinoma
(HNSCC) with immune checkpoint inhibitors (anti-PD1) with or without chemotherapy has …
(HNSCC) with immune checkpoint inhibitors (anti-PD1) with or without chemotherapy has …
E-cadherin expression pattern in head and neck squamous cell carcinoma and its association with clinico-pathological predictors
K Devaraja, S Pillai, M Valiathan, V Geetha… - The Egyptian Journal of …, 2023 - Springer
Background The molecular makeup of a head and neck squamous cell carcinoma (HNSCC)
could vary as per the geography and corresponding variability in prevalent etiopathological …
could vary as per the geography and corresponding variability in prevalent etiopathological …
Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma
M Obrenović, G Šupić, S Miyabe, I Mladenović… - Biomolecules and …, 2024 - bjbms.org
Despite significant efforts in developing new diagnostic and therapeutic modalities, oral
squamous cell carcinomas (OSCCs) still exhibit a high recurrence rate, a low five-year …
squamous cell carcinomas (OSCCs) still exhibit a high recurrence rate, a low five-year …